Sidebar is Loading...
Loading...
Brands
Resources
YSTV
ADVERTISEMENT
Loading...
Brands
Resources
YSTV
Emboline is a medical device company which has developed a device for total embolic protection during percutaneous heart valve repair and replacement procedures and other cardiovascular procedures with embolic risks.
Emboline, Inc., an emerging medical device company which has developed a device for total embolic protection during transcatheter aortic valve replacement (TAVR) procedures. The company claims that the Emboliner is a truly next-generation approach to reducing the risk of cerebral embolic events or stroke that patients may face following TAVR procedures. The Emboliner design presents significant improvements on first-generation solutions by offering more effective coverage of all cerebral branches with fewer anatomical limitations, full-body embolic protection, capturing both cerebral and non-cerebral debris, no additional procedural access required, minimal interference with devices necessary to complete the procedure, and outstanding ease-of-use and device control. In Januray 2020, the company announced the closing of a $5m bridge round of financing.
Legal Name
:
Emboline, Inc.
Headquarters
:
Santa Cruz, California, United States of America
Founding Date
:
2011
No. of Employees
:
<10
Core Team
:
1.
Amir Belson
Founder & CTO
2.
SCOTT RUSSELL
President & CEO
Total Funding
$15.0M
Investors
:
1.
SV Tech Ventures
2.
ShangBay Capital
Frequently Asked Questions
